P

Inventor

VANDENBROUCKE KLAAS

BE12 patents
⚠️ This page may combine multiple inventors who share the name “VANDENBROUCKE KLAAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INTREXON ACTOBIOTICS NV

7 patents
US9347036B2May 24, 2016

Modified gram positive bacteria and uses thereof

INTREXON ACTOBIOTICS NV4 citations82
US10519418B2Dec 31, 2019

Modified gram positive bacteria and uses thereof

INTREXON ACTOBIOTICS NV1 citations71
US10030234B2Jul 24, 2018

Modified gram positive bacteria and uses thereof

INTREXON ACTOBIOTICS NV2 citations71
US9982228B2May 29, 2018

Modified gram positive bacteria and uses thereof

INTREXON ACTOBIOTICS NV2 citations71
US10988770B2Apr 27, 2021

Polycistronic expression system for bacteria

INTREXON ACTOBIOTICS NV0 citations60
US10793825B2Oct 6, 2020

Modified gram positive bacteria and uses thereof

INTREXON ACTOBIOTICS NV0 citations50
US9458467B2Oct 4, 2016

Modified gram positive bacteria and uses thereof

INTREXON ACTOBIOTICS NV0 citations50

INTREXON ACTOBIOTICS N V

3 patents
US11384123B2Jul 12, 2022

Mucoadhesive microorganism

INTREXON ACTOBIOTICS N V2 citations71
US10808014B2Oct 20, 2020

Mucoadhesive microorganism

INTREXON ACTOBIOTICS N V4 citations71
US12252516B2Mar 18, 2025

Mucoadhesive microorganism

INTREXON ACTOBIOTICS N V0 citations61

STEIDLER LOTHAR

1 patent
US8759088B2Jun 24, 2014

Lactococcus promoters and uses thereof

STEIDLER LOTHAR21 citations87

ROTTIERS PIETER

1 patent
US9017662B2Apr 28, 2015

Anti-TNF alpha producing lactic acid bacteria for the treatment of chronic enterocolitis

ROTTIERS PIETER0 citations49